AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 195 filers reported holding AXSOME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,641,943 | -3.7% | 21,288 | -44.3% | 0.42% | -6.4% |
| Q3 2022 | $1,705,000 | +16.5% | 38,218 | 0.0% | 0.45% | +26.2% |
| Q2 2022 | $1,464,000 | -4.2% | 38,218 | +105.8% | 0.36% | -47.7% |
| Q2 2020 | $1,528,000 | -48.7% | 18,569 | -63.3% | 0.69% | -60.6% |
| Q1 2020 | $2,980,000 | -28.3% | 50,649 | +26.0% | 1.74% | +4.8% |
| Q4 2019 | $4,156,000 | +250.1% | 40,206 | -31.4% | 1.66% | +187.7% |
| Q3 2019 | $1,187,000 | -22.4% | 58,622 | -1.3% | 0.58% | -11.2% |
| Q2 2019 | $1,530,000 | +26.3% | 59,400 | -30.2% | 0.65% | +21.5% |
| Q1 2019 | $1,211,000 | – | 85,086 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |